The 18 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 26.50, with a high estimate of 42.00 and a low estimate of 18.00. The median estimate represents a +27.40% increase from the last price of 20.80.
The current consensus among 20 polled investment analysts is to Hold stock in ACADIA Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.54
Reporting Date May 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.